Immunotherapies and COVID-19 mortality: a multidisciplinary open data analysis based on FDA’s Adverse Event Reporting System.

HOME
>
論文・技術情報
>
Immunotherapies and COVID-19 mortality: a multidisciplinary open data analysis based on FDA’s Adverse Event Reporting System.

アブストラクト
ジャーナル名	Annals of the rheumatic diseases
Pubmed追加日	2021/7/22
投稿者	Pistor, Maximilian; Hoepner, Andreas G F; Lin, Yanan; Jung, Simon; Bassetti, Claudio L; Chan, Andrew; Salmen, Anke; Hoepner, Robert
組織名	Department of Neurology, Inselspital, Bern University Hospital, University of;Bern, Bern, Switzerland.;Michael Smurfit Graduate Business School-Department of Banking & Finance,;University College Dublin, Dublin, Ireland.;Platform for Sustainable Finance-Department for Financial Stability and Capital;Markets (DG FISMA), European Commission, Brussels, Belgium.;Bern, Bern, Switzerland robert.hoepner@insel.ch.
Pubmed リンク	https://www.ncbi.nlm.nih.gov/pubmed/34285050/